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Abstract
Hydrogen sulfide is a gasotransmitter with vasodilatory and anti-inflammatory properties. Aspirin is an irreversible
cyclooxygenase inhibitor anti-inflammatory drug. ACS14 is a novel synthetic hydrogen sulfide releasing aspirin which
inhibits cyclooxygenase and has antioxidant effects. Methylglyoxal is a chemically active metabolite of glucose and fructose,
and a major precursor of advanced glycation end products formation. Methylglyoxal is harmful when produced in excess.
Plasma methylglyoxal levels are significantly elevated in diabetic patients. Our aim was to investigate the effects of ACS14
on methylglyoxal levels in cultured rat aortic vascular smooth muscle cells. We used cultured rat aortic vascular smooth
muscle cells for the study. Methylglyoxal was measured by HPLC after derivatization, and nitrite+nitrate with an assay kit.
Western blotting was used to determine NADPH oxidase 4 (NOX4) and inducible nitric oxide synthase (iNOS) protein
expression. Dicholorofluorescein assay was used to measure oxidative stress. ACS14 significantly attenuated elevation of
intracellular methylglyoxal levels caused by incubating cultured vascular smooth muscle cells with methylglyoxal (30 mM)
and high glucose (25 mM). ACS14, but not aspirin, caused a significant attenuation of increase in nitrite+nitrate levels
caused by methylglyoxal or high glucose. ACS14, aspirin, and sodium hydrogen sulfide (NaHS, a hydrogen sulfide donor), all
attenuated the increase in oxidative stress caused by methylglyoxal and high glucose in cultured cells. ACS14 prevented the
increase in NOX4 expression caused by incubating the cultured VSMCs with MG (30 mM). ACS14, aspirin and NaHS
attenuated the increase in iNOS expression caused by high glucose (25 mM). In conclusion, ACS14 has the novel ability to
attenuate an increase in methylglyoxal levels which in turn can reduce oxidative stress, decrease the formation of advanced
glycation end products and prevent many of the known deleterious effects of elevated methylglyoxal. Thus, ACS14 has the
potential to be especially beneficial for diabetic patients pending further in vivo studies.
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Introduction
Hydrogen sulfide (H2S) is a physiological gasotransmitter
molecule which has vasodilatory and anti-inflammatory properties
[1,2]. Aspirin (acetylsalicylic acid) is an irreversible cyclooxygenase
inhibitor which is used as a non-steroidal anti-inflammatory drug.
Low dose aspirin (81–160 mg/day) is widely used as an
antiplatelet drug [3]. Aspirin has been shown to inhibit glycation
of lens protein by acetylation [4]. ACS14 (2-acetyloxybenzoic acid
4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl ester, Fig. 1) is a novel
synthetic H2S releasing aspirin which inhibits cyclooxygenase like
aspirin, but it spares the gastric mucosa, by a favorable redox
balance caused by increased H2S/glutathione (GSH) formation,
heme oxygenase-1 (HO-1) expression and reduced 8-isoprostane-
prostaglandin F2a (8-isoprostane) formation [5]. ACS14 increases
antioxidant defense by increasing GSH and cysteine and
decreasing homocysteine levels [6].
Methylglyoxal (MG) (pyruvaldehyde) is produced mainly during
glucose and fructose metabolism, and to a lesser extent during fatty
acid and amino acid metabolism [7]. Chemically MG is a reactive
dicarbonyl molecule which readily reacts with certain proteins and
enzymes and disrupts their structure and function [8,9]. MG is of
great pathological significance because it is a major precursor for
the formation of advanced glycation end products (AGEs) [10].
The glyoxalase enzymes and reduced glutathione (GSH) rapidly
degrade physiological amounts of MG produced in the body into
D-lactate [11,12]. An excess of MG formation, as occurs in
diabetic patients [13], causes a 3–4 fold elevation of plasma MG
levels [14,15], and is harmful.
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We have shown that incubation of vascular smooth muscle cells
(VSMCs) with 25 mM glucose or fructose for 3 h increases MG
production 3.5 or 3.9 fold, respectively, and increases oxidative
stress [16]. MG and high glucose also reduced nitric oxide (NO)
production and caused endothelial dysfunction in cultured
endothelial cells and isolated aortic rings [8]. Chronic treatment
of Sprague-Dawley rats with MG for 4 weeks induces features
characteristic of type 2 diabetes mellitus [17].
We have recently shown that H2S interacts with MG in cultured
VSMCs, in which the H2S donor sodium hydrogen sulfide (NaHS,
30, 60 and 90 mM) significantly decreased cellular MG levels [18].
Therefore, our main aim was to see if ACS14 could prevent or
attenuate the increase in intracellular MG levels and the associated
oxidative stress, caused by high glucose or exogenous MG, and our
results show that this is indeed the case.
Methods
Vascular smooth muscle cell culture
Rat thoracic aortic vascular smooth muscle cell line (VSMCs,
A-10 cells, Cat # ATCC CRL-1476; American Type Culture
Collection, Manassas, VA, USA) was cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM) containing 10% fetal bovine
serum (FBS) at 37uC in a humidified atmosphere of 95% air and
5% CO2, as described previously [19]. A-10 cells were seeded
either in 100 mm dishes for MG measurement or in 96-well plates
for other assays, with an equal amount of cells (106/ml) in each
well, and cultured to confluence. Cells were starved in FBS-free
DMEM for 24 h before exposure to different test reagents. The
concentrations of MG and NaHS were determined from previous
studies in our lab [16,18].
Methylglyoxal measurement
MG was measured by a specific and sensitive high-performance
liquid chromatography (HPLC) method [20]. MG was derivatized
with o-phenylenediamine (o-PD) to form the quinoxaline product,
2-methylquinoxaline, which is very specific for MG. For MG
measurement the cells were washed twice with phosphate buffered
saline (PBS), scrapped and cell pellets were resuspended in ice-cold
PBS, and lysed over ice by sonication (5 s, three times). The
samples were incubated in the dark for 24 h with 0.45 N
perchloric acid and 10 mM o-PD at room temperature. The
quinoxaline derivatives of MG (2-methylquinoxaline) and the
quinoxaline internal standard (5-methylquinoxaline) were quanti-
fied on a Hitachi D-7000 HPLC system (Hitachi, Ltd., Mis-
sissauga, ON, Canada) via Nova-Pak C18 column (3.96150 mm,
and 4 mm particle diameter, Waters Corporation, MA, USA).
Measurement of nitrite and nitrate
Cells were incubated with different test reagents for 24 h and
then washed with PBS. The supernatant was used for the
measurement of nitrite and nitrate with a fluorimetric assay kit
(Cat # 780051, Cayman Chemical Company, Ann Arbor, MI,
USA) based on the Greiss reaction. The assay is based on the
enzymatic conversion of nitrate to nitrite by nitrate reductase
followed by the addition of 2,3-diaminonaphthalene, which
converts nitrite to a fluorescent compound. Fluorescence intensity
measurements of this compound accurately determine the nitrite
(NO2) concentration (excitation max.: 365 nm; emission max.:
450 nm).
Measurement of oxidative stress
Oxidative stress was determined by a sensitive dicholorofluor-
escein (DCFH) assay. Briefly, cells were loaded with a membrane-
permeable, nonfluorescent probe 29, 79-dichlorofluorescein diace-
tate (CM-H2DCFDA, 5 mM) for 2 h at 37uC in FBS-free DMEM in
the dark. After washing 3 times with PBS, the cells were treated with
or without different substrates or MG for different incubation times,
and finally subjected to detection. Once inside the cells, CM-
H2DCFDA becomes membrane-impermeable DCFH2 in the
presence of cytosolic esterases, and is further oxidized by
peroxynitrite to form the fluorescent oxidized dichlorofluorescein
(DCF). The probe has high reactivity with peroxynitrite and its
products CO3˙
2 and˙ NO2 but is not entirely specific for it. It also has
low reactivity for hydrogen peroxide and even lower for superoxide
[21]. The fluorescence intensity was measured with excitation at
485 nm and emission at 527 nm utilizing a Fluoroskan Ascent plate
reader (Thermo Labsystems, Fisher Scientific Co., Ottawa, ON,
Canada) and Ascent software, and expressed in arbitrary units.
Western blotting
Cell lysate was separated by 8% or 10% SDS-PAGE, electro-
transferred onto a polyvinylidene fluoride membrane, blocked with
5% skim milk for 30 minutes and incubated with primary antibodies
diluted in skim milk overnight at 4uC. The next day, after 2 h of
thorough washing with PBST buffer (PBS with 0.1% tween-20), the
membranes were incubated with horseradish peroxidase-conjugated
secondary antibodies for 2 h at room temperature. After 1 h
washing, the immunoreactive proteins were detected with an
Enhanced Chemiluminescence Detection System. Primary antibody
for NADPH oxidase 4 (NOX4) was purchased from Santa Cruz
(Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). iNOS
antibody was from BD Transduction Laboratories (BD Biosciences,
Mississauga, ON, Canada). b-actin was purchased from Sigma
(Sigma-Aldrich Corp., St. Louis, MO, USA), and secondary anti-
rabbit and anti-mouse IgG antibodies were from Cell Signaling (Cell
Signaling Technology Inc., Danvers, MA, USA).
Cell viability assay
Cell viability was determined with a CellTiter 96 AQueous One
Solution Cell Proliferation Assay with a kit from Promega
(Promega Corp., Madison, WI, USA), following the manufactur-
er’s instructions. The assay uses MTS tetrazolium compound [3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfo-
phenyl)-2H-tetrazolium, inner salt] and phenazine ethosulfate
(PES), an electron coupling reagent. MTS is converted into a
soluble formazan product by living cells. The amount of formazan
produced correlates with viable cells. Briefly, VSMCs (A-10 cells,
105 cells/well) were plated into 96-well tissue culture plates. After
incubation with MG (30 mM) or ACS14 (30, 100 or 300 mM)
alone or in combination in 100 ml of FBS-free DMEM at 37uC for
Figure 1. Chemical structure of H2S releasing aspirin, ACS14
[2-acetyloxybenzoic acid 4-(3-thioxo-3H-1,2-dithiol-5-yl)phe-
nyl ester].
doi:10.1371/journal.pone.0097315.g001
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24 h, 20 ml of CellTiter 96 AQueous One Solution Reagent was
added to each well. After a further incubation for 4 h at 37uC in a
5% CO2 atmosphere, absorbance was measured at 490 nm using
a Multiskan Spectrum plate reader (Thermo Labsystems, Fisher
Scientific Co., Ottawa, ON, Canada).
Materials
ACS14 and aspirin were kindly provided by CTG Pharma,
Milan, Italy. Methylglyoxal, D-glucose, aspirin and NaHS were
purchased from Sigma-Aldrich Canada Ltd (Mississauga, ON,
Canada). Chemical compounds: Chemical compounds studied in
this article: 2-acetyloxybenzoic acid 4-(3-thioxo-3H-1,2-dithiol-5-
yl)phenyl ester (ACS14); Aspirin (acetylsalicylic acid) (PubChem
CID: 2244); Methylglyoxal (Pyruvaldehyde) (PubChem CID: 880);
D-glucose (Dextrose) (PubChem CID: 5793); Sodium hydrogen
sulfide (PubChem CID: 28015).
Statistics
Statistical analysis was performed using one way ANOVA and
Tukey’s post-hoc test. P,0.05 was taken as significant.
Results
ACS14 significantly attenuates elevation of intracellular
MG levels caused by MG and high glucose in cultured
cells
Incubation of cultured VSMCs with MG (30 mM) or high
glucose (25 mM) for 3 or 24 h caused a significant elevation of
intracellular MG levels (Fig. 2). Co-incubation with ACS14
significantly attenuated the increase in MG levels caused by 3 h
or 24 h incubation with MG (Fig. 2A, B), or 24 h incubation with
high glucose (Fig. 2D). Aspirin only significantly attenuated
elevation of MG level caused by 3 h incubation with MG
(Fig. 2A). NaHS caused a significant attenuation of increase in MG
levels caused by 3 h incubation with MG and 24 h incubation
with high glucose (Fig. 2A, D). The 3 h time point to measure MG
levels was chosen based on our previous observation that MG
levels in cultured VSMCs peaked at 3 h after incubation with
fructose [22] and increased significantly at 3 h after incubation
with glucose [16]. The 24 h time point was chosen as a standard
time-point to measure changes in protein expression in cultured
cells.
ACS14, but not aspirin, causes a significant attenuation
of increase in nitrate+nitrite levels and iNOS expression
caused by MG and/or high glucose in cultured cells
Incubation of cultured VSMCs with high glucose (25 mM) for
24 h caused a significant elevation of nitrate+nitrite levels (Fig. 3B).
Co-incubation with ACS14 significantly decreased the nitrate+
nitrite levels compared to MG treated cells (Fig. 3A) and also
attenuated the increase in nitrate+nitrite levels caused by 24 h
incubation with high glucose (Fig. 3B). Aspirin co-treated cells did
not have significantly lower levels of nitrite+nitrate compared to
MG treated cells (Fig. 3A) or high glucose treated cells (Fig. 3B).
NaHS co-treatment caused a significant attenuation of increase in
nitrate+nitrite caused by incubation with high glucose (Fig. 3B).
Figure 2. ACS14 significantly attenuates elevation of intracellular MG levels caused by MG and high glucose in cultured cells.
Cultured rat aortic vascular smooth muscle cells (VSMCs, A10 cell line) were incubated with methylglyoxal (MG, 30 mM) or high glucose (25 mM) alone
or co-incubated with either ACS14 (100 mM), or aspirin (100 mM) or sodium hydrogen sulfide (NaHS, 90 mM) for 3 h or 24 h. MG levels in the cells were
measured after derivatizing MG with ortho-phenylenediamine to form 2-methylquinoxaline, which was detected with HPLC. *P,0.05 and **P,0.01
vs. respective control, {P,0.05 vs. respective MG group or high glucose group.
doi:10.1371/journal.pone.0097315.g002
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ACS14, aspirin and NaHS also attenuated the increase in iNOS
expression caused by high glucose (25 mM) incubation for 24 h in
VSMCs (Fig. 3C).
ACS14, aspirin, and sodium hydrogen sulfide, all
attenuate the increase in oxidative stress caused by MG
and high glucose in cultured cells
Incubation of cultured VSMCs with MG (30 mM) or high
glucose (25 mM) for 24 h caused a significant elevation of
oxidative stress measured as oxidized-DCF (Fig. 4). Co-incubation
with either ACS14 (100 mM), aspirin (100 mM) or NaHS (90 mM)
significantly prevented the increase in oxidative stress caused by
24 h incubation with either MG (30 mM) or high glucose (Fig. 4A,
B). Since, NADPH oxidase is a major source of superoxide
Figure 3. ACS14, but not aspirin, causes a significant attenu-
ation of increase in nitrite+nitrate levels caused by MG or high
glucose in cultured cells. Cultured rat aortic vascular smooth muscle
cells (VSMCs, A10 cell line) were incubated with methylglyoxal (MG,
30 mM) (A), or high glucose (25 mM) (B, C), alone or co-incubated with
either ACS14 (100 mM), or aspirin (100 mM) or sodium hydrogen sulfide
(NaHS, 90 mM) for 24 h. Nitrite+nitrate levels in the supernatant were
measured with the Griess assay kit (A, B). Expression of iNOS protein
was determined with Western blotting (C). *P,0.05 vs. respective
control, {P,0.05 and {{P,0.01 vs. respective MG group or high glucose
group.
doi:10.1371/journal.pone.0097315.g003
Figure 4. ACS14, aspirin, and sodium hydrogen sulfide, all
attenuate the increase in oxidative stress caused by MG and
high glucose in cultured cells. Cultured rat aortic vascular smooth
muscle cells (VSMCs, A10 cell line) were incubated with methylglyoxal
(MG, 30 mM) (A, C), or high glucose (25 mM) (B), alone or co-incubated
with either ACS14 (100 mM), or aspirin (100 mM) or sodium hydrogen
sulfide (NaHS, 90 mM) for 24 h. Oxidative stress (mainly peroxynitrite
formation) was measured as oxidized dichlorofluorescein (DCF) (A, B).
Western blotting was performed to measure NOX4 protein expression
(C). *P,0.05 vs. respective control, {P,0.05 and {{P,0.01 vs. respective
MG group or high glucose group.
doi:10.1371/journal.pone.0097315.g004
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formation, an analysis of NOX4 protein showed significant
elevation of NOX4 expression in cultured VSMCs incubated
with MG (30 mM), which was attenuated by co-incubation with
ACS14 (100 mM), but not with aspirin or NaHS (Fig. 4C).
Methylglyoxal and ACS14 reduce cell viability of cultured
vascular smooth muscle cells
Incubation of cultured VSMCs with ACS14 (30 mM) did not
affect cell viability compared to control, but ACS14 (100 mM)
alone caused about 15% decrease in cell viability (Fig. 5). ACS14
(300 mM) decreased cell viability by about 23%. MG (30 mM)
alone decreased cell viability by about 12% (Fig. 5) whereas MG
(30 mM) coincubated with ACS14 (30 mM) reduced cell viability
by about 15%, and with ACS14 (100 mM) by about 20%. MG
(30 mM) plus ACS14 (300 mM) reduced cell viability by about 38%
(Fig. 5).
Discussion
Here we show a novel effect of the H2S releasing aspirin,
ACS14, to attenuate an increase in MG levels caused by treating
cultured VSMCs with either exogenous MG or high glucose.
ACS14 also reduced oxidative stress caused by MG or high
glucose in VSMCs and also significantly reduced increased
expression of NOX4 caused by MG. Moreover, ACS14 attenu-
ated the increase in nitrite+nitrate levels caused by high glucose.
The ability of ACS14 to attenuate the increase in MG levels
caused by exogenous MG or high glucose is an attractive feature of
this novel drug. Endogenous glucose and fructose metabolism are
the main sources of MG formation in the body [7,16,23,24]. An
excess of MG formation in the body as seen in diabetic patients
[14,15] and rats fed a high fructose diet [23,25] is harmful and can
cause pathologies such as endothelial dysfunction and features of
type 2 diabetes [8,17]. Moreover, MG is a major precursor for the
formation of AGEs [10]. The reaction of MG with arginine
produces hydroimidazolones such as Ne-(5-hydro-5-methyl-4-
imidazolon-2-yl)-ornithine and argpyrimidine [26], whereas with
lysine it forms Ne-carboxyethyllysine CEL [27]. Thus, ACS14 has
the potential to prevent the harmful effects of elevated MG and
also provide antithrombosis [28] in diabetic patients, who have an
increased risk of developing cardiovascular complications. We
have previously shown that H2S provided by NaHS decreases MG
levels in VSMCs [18].
ACS14 also reduced oxidative stress. We are using the term
‘‘oxidative stress’’ because the probe 29,79-dichlorofluorescein
diacetate (CM-H2DCFDA) is not absolutely specific for perox-
ynitrite even though it has high specificity for peroxynitrite and
low for hydrogen peroxide and superoxide [21]. ACS14 has been
shown to reduce oxidative stress in other studies [5,6]. MG is a
major trigger for increasing oxidative stress [29,30] and since
ACS14 prevents an increase in MG levels, this could be one of the
mechanisms by which ACS14 reduces oxidative stress besides
causing an increase in the antioxidant GSH levels [6]. We have
previously shown that MG and high glucose can increase oxidative
stress [8,16,29,31], which can be attributed to increased activity of
NADPH oxidase [8] [8]and NF-kB [29]. We have also shown that
MG and high glucose can increase the expression of NF-kB and
NOX4 protein in cultured VSMCs and human umbilical vein
endothelial cells [31]. MG is a potent inducer of oxidative stress as
discussed in a review by us [30], and scavenging MG would
prevent activation of multiple pathways of increased free radical
generation. Thus, incubation of cultured VSMCs with 30 mM MG
for 24 h increased the expression of NOX4, which was attenuated
by co-incubation with ACS14. The reduced expression of NOX4
caused by ACS14 in the current study could be due to an
attenuation of MG levels in VSMCs. NOX4 is a potential source
of superoxide and increased oxidative stress in VSMCs [32,33].
ACS14, but not aspirin, attenuated an increase in nitrite+nitrate
levels caused by high glucose. High glucose caused increased
expression of iNOS which was attenuated by ACS14 (Fig. 3C). We
have previously shown that MG caused an increase in nitrite+
nitrate levels in VSMCs, most probably coming from increased
expression of inducible nitric oxide synthase (iNOS) [16].
Increased nitric oxide production from iNOS can potentially
react with superoxide and cause increased peroxynitrite formation
detected as oxidized dichlorofluorescein in the current study.
ACS14 100 mM caused about 15% decrease in cell viability
whereas 30 mM of ACS14 did not. Thus, about 85% of cells
survived at ACS14 100 mM (vs. control). ACS14 at 100 mM
produced more consistent attenuation of the effects of MG and
since cell viability decreased by only about 15% at that
concentration we decided to use 100 mM of ACS14. The results
of cell viability also caution us not to use ACS14 beyond a certain
concentration or dose due to increased cytotoxicity with higher
concentrations. This makes sense because H2S has been shown to
be toxic at higher concentrations.
Limitations of the study. Besides NOX4 we have previously
shown that MG and high glucose increase the expression of NF-kB
in cultured VSMCs [29,31]. Thus, it would have been useful to
examine the effect of MG and ACS14 on NF-kB expression.
Similarly, it would have been useful to measure levels of reduced
and oxidized glutathione since high glucose and MG have been
shown to reduce levels of reduced glutathione (GSH) and
expression of glutathione reductase in cultured human umbilical
vein endothelial cells [8]. Although NOX1 and NOX4 are
expressed in rat VSMCs, they have different subcellular locations
and functions [33]. For example one study has shown that NOX1
mediated angiotensin II induced superoxide production in rat
VSMCs with a four-fold increase in NOX1 mRNA after 8 h and a
40% decrease in NOX4 mRNA [34]. Thus, it is possible that
different isoforms respond to different ligands and they might even
be antagonistic to each other. For example, in VSMCs from the
aortas of mice after incubation with high glucose (25 mM) for
24 h, NOX4 expression increased by 250630% whereas NOX1
increased by only 7069% [32]. Since in our previous study NOX4
Figure 5. MG and ACS14 significantly reduce cell viability of
cultured vascular smooth muscle cells. Cultured rat aortic vascular
smooth muscle cells (VSMCs, A10 cell line) were incubated with
methylglyoxal (MG, 30 mM) or ACS14 (30, 100 or 300 mM), alone or
combined, for 3 h. Cell viability was determined with CellTiter 96
AQueous One Solution Cell Proliferation Assay as described in the
methods. ***P,0.001 vs. respective control, {{{P,0.001 vs. MG alone
group.
doi:10.1371/journal.pone.0097315.g005
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expression increased after high glucose (25 mM) and MG (30 mM)
[31], we examined the effect of ACS14 on NOX4 expression.
However, it would be interesting to examine the effect of MG on
NOX1 expression.
A strong link between oxidative stress and inflammation has
been reported previously [35,36]. Our lab has also previously
shown that incubation of neutrophils with MG (20 mM) for 12 h
increases secretion of tumor necrosis factor-a (TNF-a), interleukin-
6 (IL-6) and interleukin-8 (IL-8) [14]. Thus, it would have been
useful to examine markers of inflammation, but aspirin is well
established as an anti-inflammatory drug. Moreover, the anti-
inflammatory effect of ACS14 has been previously demonstrated
in cultured microglial cells [37].
In conclusion, ACS14 has the novel ability to attenuate an
increase in MG levels which in turn can reduce oxidative stress,
decrease AGEs formation and prevent many of the known
deleterious effects of elevated MG. Thus, ACS14 has the potential
to be especially beneficial for diabetic patients for which further in
vivo studies are required.
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